GB/Z 42246-2022
ActiveNanotechnologies—Guideline on genotoxicity test methods for nanomaterials
纳米技术 纳米材料遗传毒性试验方法指南
Application Summary AI generated
This standard provides a guideline for selecting and applying appropriate genotoxicity test methods specifically for nanomaterials, addressing challenges like interference with assay components and unique physicochemical properties. It is applied in the healthcare and pharmaceutical industries for evaluating the potential DNA-damaging effects of nanomaterials used in medical devices, drug delivery systems, and diagnostic agents. The guideline supports regulatory safety assessments and risk management during the development and quality control of nanomaterial-based products.
Related Standards
NY 5071-2002
Pollution-free Food - Guidelines for the Use of Fishery Drugs
GB/T 19618-2004
The licorice
GB/Z 42344-2023
Verify guidance for computerized system of pharmaceutical machinery (equipment)
GB/Z 42540-2023
Technical guide for containment of pharmaceutical equipment—Solid preparations
GB/T 19116-2003
Lycium culture technics operatings
GB/T 15692.6-1995
Terms of pharmaceutical machinery--Water treatmet eqiupment for pharmaceutical use
GB/T 15692.9-1995
Terms of pharmaceutical machinery--Other pharmaceu-tical machinery and equipment
GB/T 15692.7-1995
Terms of pharmaceutical machinery--Pharmaceutical packaging machinery
Transparency note: The application summary and key sentences on this page were automatically generated by AI from the standard's original text. This content has not been human-verified and should not be used for compliance or regulatory purposes. Always refer to the official standard document from the issuing authority.